Anicin et al. (74) demonstrate that laryngeal SCC patients who show protein expression of the cathepsin inhibitor stefin A have a better survival outcome than those without expression of stefan A. Similarly, Li et al. (75) show that overexpression of stefin A in esophageal SCC is associated with improved survival. Here, CTSS is linked to esophageal squamous cell carcinoma.